Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remsima in Chronic Plaque Psoriasis
NCT06043752Phase 4Completed
- Sponsor
- Ghurki Trust and Teaching Hospital
- Start
- Mar 2022
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in plaque psoriasis, sponsored by Ghurki Trust and Teaching Hospital. Started Mar 2022; status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06043752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06043752.